Immune System: Page 5

MedImmune acquires rights to Inovio's HPV vaccine
By DrBicuspid.com staff writers
Inovio Pharmaceutial has entered into a license agreement with MedImmune for its INO-3112 immunotherapy for cancers caused by human papillomavirus (HPV) and also a collaboration to develop new cancer vaccines, the companies announced.
August 9, 2015
OncoSec enrolls 1st patient in immunotherapy clinical trial
By DrBicuspid.com staff writers
OncoSec Medical has enrolled the first patient in a phase II clinical trial that uses ImmunoPulse IL-12, an immunotherapy platform, to treat patients with squamous cell carcinoma of the head and neck.
June 17, 2015
Erectile dysfunction drug shows promise for HNSCC
By Donna Domino
The little yellow pills that have boosted men's sex lives for the past decade may someday fight head and neck cancers and other diseases, according to Florida researchers. The erectile dysfunction drug tadalafil, commonly known as Cialis, can modulate the body's immune system, resulting in a new therapeutic strategy for head and neck squamous cell carcinoma (HNSCC), a new trial has shown.
May 26, 2015
2015 04 20 15 39 28 178 Cancer Cell Target 200
Study finds how T cells cause inflammation with oral candidiasis
By Donna Domino
Ohio dental researchers have found a method to study how T cells cause inflammation during oral candidiasis infections, according to a new study in the Journal of Visualized Experiments. The discovery can lead to new therapies or drugs that jump-start weakened or poorly functioning immune systems.
March 9, 2015
2015 03 09 19 15 08 618 Candida 200
Japanese mushroom may help treat HPV infection
By DrBicuspid.com staff writers
A Japanese mushroom extract appears to be effective in eradicating human papillomavirus (HPV), according to a pilot clinical trial at the University of Texas Medical School at Houston
November 12, 2014
2013 09 03 14 41 25 490 Hpv 200
Study: Immune-related gene may predispose to HPV-related cancer
By DrBicuspid.com staff writers
An international coalition of cancer specialists has identified an immune-related gene called transforming growth factor beta receptor 1 (TGFBR1) that appears to play a pivotal role in determining whether a person develops HPV-related cancer. Their findings are discussed in the journal Cancer Research.
October 23, 2014
Study: Cancer prognosis related to newly identified immune cells
By DrBicuspid.com staff writers
A newly discovered type of immune cells in tumors is associated with less severe cancer outcomes in humans and may have therapeutic potential, according to a new study in the journal Cancer Cell. The better outcomes were especially strong in head and neck cancers and in breast cancers, the researchers found.
October 23, 2014
2013 12 26 15 30 33 820 Cancer Thru Magnifying Glass 200
Study: Unusual immune cell needed to prevent oral thrush
By DrBicuspid.com staff writers
An unusual kind of immune cell in the tongue appears to play a pivotal role in preventing thrush, according to a new study. The findings may suggest why some patients are more susceptible to this oral yeast infection and could lead to the development of treatments in these highly vulnerable patients.
September 8, 2014
2014 09 08 16 07 08 578 Candida 200
Advaxis, MedImmune partner on clinical trial
By DrBicuspid.com staff writers
Advaxis, a biotechnology company that develops cancer immunotherapies, has entered a clinical trial collaboration with MedImmune, the biologics research and development arm of AstraZeneca.
July 21, 2014
Study finds link between perio disease, atherosclerosis
By DrBicuspid.com staff writers
Chronic oral infection with the periodontal disease pathogen Porphyromonas gingivalis not only causes local inflammation of the gums leading to tooth loss but is also associated with an increased risk of atherosclerosis, according to a study in PLOS Pathogens.
July 14, 2014
Study: Periodontitis bacteria selectively disarms immune system
By Donna Domino
The periodontal bacterium Porphyromonas gingivalis acts on two molecular pathways to simultaneously block immune cells' killing ability while preserving the cells' ability to cause inflammation, according to a new study in Cell Host & Microbe.
June 17, 2014
2013 04 29 16 40 49 422 Bacteria 200
PeriRx to launch new Sjögren's syndrome test
By DrBicuspid.com staff writers
PeriRx announced it will introduce a molecular biomarker test for the early detection of Sjögren's syndrome by the end of 2014.
May 29, 2014
Previous Page
Page 5 of 8
Next Page